A5011981586- Heart Failure Treatment and Management
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Phonocardiography and Auscultation Techniques
- Ultrasound in Clinical Applications
- Blood Pressure and Hypertension Studies
- Potassium and Related Disorders
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Chemotherapy-induced cardiotoxicity and mitigation
- Hemodynamic Monitoring and Therapy
- Cardiac Structural Anomalies and Repair
- Ultrasound and Hyperthermia Applications
- Cancer-related cognitive impairment studies
- Mechanical Circulatory Support Devices
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Cardiac Arrest and Resuscitation
Hospital Universitari de Girona Doctor Josep Trueta
2017-2025
Hospital de Sant Pau
2019-2021
Centro de Investigación en Red en Enfermedades Cardiovasculares
2019-2021
Universitat Autònoma de Barcelona
2019-2021
Abstract Aims Residual pulmonary congestion at hospital discharge can worsen the outcomes in patients with heart failure (HF) and be detected by lung ultrasound (LUS). The aim of this study was to analyse prevalence subclinical its impact on prognosis admitted for acute HF. Methods results This is a post‐hoc analysis LUS‐HF trial. LUS performed investigators eight chest zones pocket device. Physical exam subsequently treating physicians. Primary outcome combined endpoint rehospitalization,...
Vericiguat, an oral stimulator of soluble guanylate cyclase, reduces cardiovascular mortality and hospitalisations in patients with heart failure (HF) reduced ejection fraction, as demonstrated the VICTORIA trial. This study assessed real-world use vericiguat. cross-sectional, prospective multicenter registry (VERISEC) included 776 from 43 centres Spain between December 2022 October 2023. Of these patients, 79.6% were male, a mean age 72.4 (SD:8.7) years. Patients VERISEC older had more...
Sacubitril/valsartan (SV) promotes cardiac remodeling and improves prognosis in patients with heart failure (HF). However, the response to drug may vary between its implementation daily clinical practice has been slower than expected. Our objective was develop a score predicting super-response SV HF outpatients. This is retrospective analysis of 185 consecutive prescribed from two tertiary hospitals September 2016 February 2018. Super-responder defined as patient taking (i) without...
Albuminuria could potentially emerge as a novel marker of congestion in acute heart failure. However, the current evidence linking albuminuria and patients with congestive failure (CHF) remains somewhat scarce. This study aimed to evaluate prevalence cohort CHF, identify independent factors associated analyse correlation different parameters. is subanalysis Spanish Cardiorenal Registry, which we enrolled 864 outpatients value urinary albumin:creatinine ratio (UACR) at first visit. The median...
Introduction and Objectives: A comprehensive assessment of congestion, including circulating biomarkers, is recommended in patients with acute heart failure. The biomarkers natriuretic peptides (NPs) carbohydrate antigen-125 (CA125) could be useful for congestion ambulatory chronic failure (CHF), but there only limited information about their applicability this context. Therefore, study aimed to examine the association plasma CA125 NP levels clinical ultrasound parameters CHF. Methods: This...
Myocardial infarction type 2 (MIT2) is caused by an ischemic imbalance, where a condition other than coronary artery disease contributes to myocardial necrosis documented dynamic change in cardiac markers.Such patients were usually not included randomized trials of ACS and little known on how they should be managed.We compared the characteristics management NSTEMI 1 (MIT1) MIT2 French FAST-MI 2015 registry, which collected information all admitted for AMI 78% institutions during one...
Acute coronary syndromes 793frequent admission (F-day) were defined as the days on which ≥6 patients admitted for uAP, whereas of non-frequent (N-day) those <6 patients.A variety daily local climate parameters including mean/maximum/minimum temperature (°C), relative humidity (%), atmospheric pressure (hPa) and sunshine duration (hours) each day was obtained from Japan Meteorological Agency.Additionally, intraday differences (maximum -minimum temperature) onset (day 0), before -1) 2 -2)...
Abstract Funding Acknowledgements none OnBehalf Background Chemotherapy cardiotoxicity is a serious complication in breast and haematological malignancies. However, its primary prevention with angiotensin converting enzyme inhibitors (ACEI)/angiotensin II receptor antagonists (ARB) and/or beta-blockers (BB) medication has discrepant results. The aim of our study was to establish whether using these treatments prevents any them superior the others. Methods A systematic review meta-analysis...